Stand Up To Cancer launched four new teams aimed at detecting and treating cancer in its earliest stages. Lung cancer expert Julie Brahmer, M.D., is the lead investigator for Johns Hopkins for lung cancer studies based at the Kimmel Cancer Center Thoracic Center of Excellence she directs. Victor Velculescu, M.D., Ph.D., an expert in the development of tests that use cancer DNA for early detection, pathologist Edward Gabrielson, M.D., lung cancer expert Patrick Forde, M.D., and David Feller-Kopman, M.D., director of interventional pulmonology, are collaborating with Brahmer.
The new project, dubbed “Cancer Interception,” includes four teams of top researchers who will carry out an attack on cancers of the lung using a radical new approach of “interception” of cancers at very early stages, when they can be more successfully treated, according to an announcement from the American Association for Cancer Research.
Stand Up To Cancer (SU2C) is joined by LUNGevity and the American Lung Association in funding the new research.
Read the full announcement.